Personalized Treatment Selection for Metastatic Breast Cancer
Status:
Terminated
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if researchers can use genetic tests to
predict who may benefit from treatment with SprycelTM (dasatinib) or selumetinib (AZD6244).